Pattern Announces Commencement of Synergy and Efficacy Testing for Promising High-grade Serous Ovarian Cancer Program Combinations
REDMOND, WA, May 22, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") proudly announces the initiation of synergy and efficacy testing for two promising drug combinations identified within its High-Grade Serous Ovarian Cancer (HGSOC) program. Armed with a [...]